Brain tumors and driving

Por McDonald, Kerrie Leanne
Publicado em 2010

NT-20 TARGETING CDK4 AND 6 IN THE CLASSICAL SUBTYPE OF GLIOBLASTOMA

Por Madani, Daniel, Nixdorf, Sheri, McDonald, Kerrie
Publicado em 2014

Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?

Por McDonald, Kerrie L., Aw, Grace, Kleihues, Paul
Publicado em 2013

MIF-CD74 GUIDED THERAPEUTIC STRATEGY FOR THE UPFRONT TREATMENT OF GBM PATIENTS WITH AN UNMETHYLATED MGMT PROMOTER

Por McDonald, Kerrie L, Ha, Wendy, Sevim, Hatice
Publicado em 2014

CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?

Por Schröder, Lisette B. W., McDonald, Kerrie L.
Publicado no Front Oncol (2015)

ET-56 SENSITIZATION OF GLIOBLASTOMA CELLS TO IRRADIATION BY MODULATING THE GLUCOSE METABOLISM

Por Shen, Han, Hau, Eric, Dilda, Pierre, McDonald, Kerrie
Publicado em 2014

EG-11 DYSREGULATION OF MGMT IN GLIOBLASTOMA: FRIEND OR FOE?

Por Rapkins, Robert W., Hitchins, Megan P., McDonald, Kerrie L.
Publicado em 2014

ATPS-54 GENOMICALLY UNSTABLE GLIOBLASTOMA (U-GBM) SHOW EXQUISITE SENSITIVITY TO PARP INHIBITION

Por McDonald, Kerrie, Joshi, Swapna, Jue, Toni Rose, Yin, Julia, Khasraw, Mustafa
Publicado no Neuro Oncol (2015)

ATPS-09 A MITOCHONDRIAL METABOLISM INHIBITOR RADIO-SENSITIZES GLIOBLASTOMA TUMOURS IN MICE

Por Chung, Sylvia, Decollogne, Stephanie, Ha, Wendy, Dilda, Pierre, Hogg, Philip, McDonald, Kerrie
Publicado no Neuro Oncol (2015)

HG-16 THE ANTI-APOPTOTIC PROTEIN ARC IS OVER-EXPRESSED IN MALIGNANT GLIOMA AND CORRELATES WITH PATIENT OUTCOME

Por Kankean, Anne, Tsoli, Maria, Tsang, Joanna, Chitranjan, Arjanna, Maleki, Sanaz, McDonald, Kerrie, Ziegler, David
Publicado no Neuro Oncol (2015)

The evolving roles and controversies of radiotherapy in the treatment of glioblastoma

Por Hau, Eric, Shen, Han, Clark, Catherine, Graham, Peter H., Koh, Eng‐Siew, L. McDonald, Kerrie
Publicado no J Med Radiat Sci (2016)

DD-04 PENAO: A POTENT MITOCHONDRIAL TARGETED INHIBITOR FOR GLIOBLASTOMA

Por Chung, Sylvia, Decollogne, Stephanie, Luk, Peter, Shen, Han, Ha, Wendy, Day, Bryan, Stringer, Brett, Hogg, Philip, Dilda, Pierre, McDonald, Kerrie
Publicado em 2014

Dual-targeting of aberrant glucose metabolism in glioblastoma

Por Shen, Han, Decollogne, Stephanie, Dilda, Pierre J, Hau, Eric, Chung, Sylvia A, Luk, Peter P, Hogg, Philip J, McDonald, Kerrie L
Publicado no J Exp Clin Cancer Res (2015)

Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology

Por Adams, Seray, Teo, Charles, McDonald, Kerrie L., Zinger, Anna, Bustamante, Sonia, Lim, Chai K., Sundaram, Gayathri, Braidy, Nady, Brew, Bruce J., Guillemin, Gilles J.
Publicado no PLoS One (2014)

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

Por Rapkins, Robert W., Wang, Fan, Nguyen, HuyTram N., Cloughesy, Timothy F., Lai, Albert, Ha, Wendy, Nowak, Anna K., Hitchins, Megan P., McDonald, Kerrie L.
Publicado no Neuro Oncol (2015)

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma

Por Jue, Toni Rose, Nozue, Kyoko, Lester, Ashleigh J., Joshi, Swapna, Schroder, Lisette B. W., Whittaker, Shane P., Nixdorf, Sheri, Rapkins, Robert W., Khasraw, Mustafa, McDonald, Kerrie L.
Publicado no J Transl Med (2017)

A Metabolic Shift Favoring Sphingosine 1-Phosphate at the Expense of Ceramide Controls Glioblastoma Angiogenesis

Por Abuhusain, Hazem J., Matin, Azadeh, Qiao, Qiao, Shen, Han, Kain, Nupur, Day, Bryan W., Stringer, Brett W., Daniels, Benjamin, Laaksonen, Maarit A., Teo, Charlie, McDonald, Kerrie L., Don, Anthony S.
Publicado em 2013

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes

Por Duncan, Christopher G., Killela, Patrick J., Payne, Cathy A., Lampson, Benjamin, Chen, William C., Liu, Jeff, Solomon, David, Waldman, Todd, Towers, Aaron J., Gregory, Simon G., McDonald, Kerrie L., McLendon, Roger E., Bigner, Darell D., Yan, Hai
Publicado em 2010

A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Ac...

Por Kast, Richard E., Boockvar, John A., Brüning, Ansgar, Cappello, Francesco, Chang, Wen-Wei, Cvek, Boris, Dou, Q. Ping, Duenas-Gonzalez, Alfonso, Efferth, Thomas, Focosi, Daniele, Ghaffari, Seyed H., Karpel-Massler, Georg, Ketola, Kirsi, Khoshnevisan, Alireza, Keizman, Daniel, Magné, Nicolas, Marosi, Christine, McDonald, Kerrie, Muñoz, Miguel, Paranjpe, Ameya, Pourgholami, Mohammad H., Sardi, Iacopo, Sella, Avishay, Srivenugopal, Kalkunte S., Tuccori, Marco, Wang, Weiguang, Wirtz, Christian R., Halatsch, Marc-Eric
Publicado em 2013